| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS709820 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS709642 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS709880 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS709882 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS709885 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS709922 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIES | CS709886 | 5x5um | ORIGENE TECHNOLOGIES |
| Interleukin 1, beta (IL1B) from ORIGENE TECHNOLOGIES | LY400196 | 100 ug | ORIGENE TECHNOLOGIES |
| Unkempt homolog (Drosophila)-like (UNKL), transcript variant 1 from ORIGENE TECHNOLOGIES | LY434369 | 100 ug | ORIGENE TECHNOLOGIES |
| Unkempt homolog (Drosophila)-like (UNKL), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422146 | 100 ug | ORIGENE TECHNOLOGIES |
| Unkempt homolog (Drosophila)-like (UNKL), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425609 | 100 ug | ORIGENE TECHNOLOGIES |
| Unkempt homolog (Drosophila) (UNK) from ORIGENE TECHNOLOGIES | LY421636 | 100 ug | ORIGENE TECHNOLOGIES |
| UNK - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415535 | 1 kit | ORIGENE TECHNOLOGIES |
| Unk - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN518718 | 1 kit | ORIGENE TECHNOLOGIES |
| UNKL - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401609 | 1 kit | ORIGENE TECHNOLOGIES |
| UNKL Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH314684 | 10 ug | ORIGENE TECHNOLOGIES |
| UNKL Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301609 | 10 ug | ORIGENE TECHNOLOGIES |
| Unkl - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN518719 | 1 kit | ORIGENE TECHNOLOGIES |
| APOBEC3A Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH320995 | 10 ug | ORIGENE TECHNOLOGIES |
| APOBEC3B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422712 | 1 kit | ORIGENE TECHNOLOGIES |
| APOBEC3C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403971 | 1 kit | ORIGENE TECHNOLOGIES |
| APOBEC3C Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303971 | 10 ug | ORIGENE TECHNOLOGIES |
| APOBEC1 complementation factor (A1CF), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415195 | 100 ug | ORIGENE TECHNOLOGIES |
| APOBEC1 complementation factor (A1CF), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430070 | 100 ug | ORIGENE TECHNOLOGIES |
| APOBEC1 complementation factor (A1CF), transcript variant 2 from ORIGENE TECHNOLOGIES | LY408475 | 100 ug | ORIGENE TECHNOLOGIES |
| APOBEC1 complementation factor (A1CF), transcript variant 3 from ORIGENE TECHNOLOGIES | LY408476 | 100 ug | ORIGENE TECHNOLOGIES |
| APOBEC3D - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416825 | 1 kit | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 1 (MAPK1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY408481 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 1 (MAPK1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419132 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 14 (MAPK14), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400523 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 10 (MAPK10), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419129 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 10 (MAPK10), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403373 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 14 (MAPK14), transcript variant 3 from ORIGENE TECHNOLOGIES | LY408440 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 14 (MAPK14), transcript variant 2 from ORIGENE TECHNOLOGIES | LY408439 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 3 (MAPK3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400968 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 3 (MAPK3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421885 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 3 (MAPK3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425672 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 14 (MAPK14), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430080 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 3 (MAPK3), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426307 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 7 (MAPK7), transcript variant 3 from ORIGENE TECHNOLOGIES | LY419130 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 7 (MAPK7), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403374 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-a1 from ORIGENE TECHNOLOGIES | LY400970 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-a2 from ORIGENE TECHNOLOGIES | LY408403 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a1 from ORIGENE TECHNOLOGIES | LY408411 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-b1 from ORIGENE TECHNOLOGIES | LY408400 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a2 from ORIGENE TECHNOLOGIES | LY400972 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-b2 from ORIGENE TECHNOLOGIES | LY408401 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 8 (MAPK8), transcript variant JNK1-b1 from ORIGENE TECHNOLOGIES | LY430088 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-b1 from ORIGENE TECHNOLOGIES | LY408412 | 100 ug | ORIGENE TECHNOLOGIES |
| Mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-b2 from ORIGENE TECHNOLOGIES | LY408413 | 100 ug | ORIGENE TECHNOLOGIES |